Cancer52 has prepared a briefing for a Westminster Hall Debate  on the ‘Potential merits of a cancer strategy for England’ . The debate...

We are delighted to welcome a new member! The Sophie Fitzpatrick Charitable Foundation for Rare Cancers.

Cancer52 is delighted to announce the appointment of Chris Walden as our new CEO.

Cancer52 are delighted to welcome The Young Tongues as the latest member to join Cancer52. The Young Tongues provide peer-to-peer support...

Cancer52 is delighted to present its Annual Review 2020-21. This report particularly highlights the strength and impact of Cancer52’s...

The first quarterly All Member Meeting of 2020 is taking place on Wednesday 22nd January 2020, from 10am to 1pm in the Allen Room at St...

Rapid Diagnostic Centres (RDCs) and the roll out of personalised care are cornerstones of the implementation plans for Cancer Alliances...

The annual All Stakeholder Briefing was a great success and we had a good turnout of both member organisations and pharmaceutical...

On Wednesday 10th July we launched a new report, ‘Getting a better deal for people with rare and less common cancers: what we can learn...

Cancer52 held a roundtable on 4th April 2019 to explore the implications of the NHS Long Term Plan and what it means for rare and less...